131 related articles for article (PubMed ID: 26356810)
41. Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
Peng JW; Lin GN; Xiao JJ; Jiang XM
Asia Pac J Clin Oncol; 2012 Dec; 8(4):356-61. PubMed ID: 22897940
[TBL] [Abstract][Full Text] [Related]
42. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery.
Wen WH; Liu JY; Qin WJ; Zhao J; Wang T; Jia LT; Meng YL; Gao H; Xue CF; Jin BQ; Yao LB; Chen SY; Yang AG
Hepatology; 2007 Jul; 46(1):84-94. PubMed ID: 17596868
[TBL] [Abstract][Full Text] [Related]
43. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
[TBL] [Abstract][Full Text] [Related]
44. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
45. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
46. Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.
Bi X; Jin Y; Gao X; Liu F; Gao D; Jiang Y; Liu H
Eur J Mass Spectrom (Chichester); 2013; 19(2):111-21. PubMed ID: 24261083
[TBL] [Abstract][Full Text] [Related]
47. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH
Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395
[TBL] [Abstract][Full Text] [Related]
48. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
[TBL] [Abstract][Full Text] [Related]
49. Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo.
Wang L; Feng J; Da L; Li Y; Li Z; Zhao M
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):213-9. PubMed ID: 23296076
[TBL] [Abstract][Full Text] [Related]
50. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; EsparÃs-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F
Gut; 2015 Sep; 64(9):1454-65. PubMed ID: 25183205
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
52. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
Lin X; Qian GS; Lu PX; Wu L; Wen YM
J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118
[TBL] [Abstract][Full Text] [Related]
53. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
[TBL] [Abstract][Full Text] [Related]
54. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
[TBL] [Abstract][Full Text] [Related]
55. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
56. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression.
Liu W; Lin YT; Yan XL; Ding YL; Wu YL; Chen WN; Lin X
FASEB J; 2015 Mar; 29(3):1113-23. PubMed ID: 25466893
[TBL] [Abstract][Full Text] [Related]
58. Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery.
Yang CC; Huang EY; Li HC; Su PY; Shih C
PLoS One; 2014; 9(10):e106683. PubMed ID: 25360769
[TBL] [Abstract][Full Text] [Related]
59. Small interfering RNA-mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma.
Hajiasgharzadeh K; Somi MH; Shanehbandi D; Mokhtarzadeh A; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3263-3276. PubMed ID: 30362510
[TBL] [Abstract][Full Text] [Related]
60. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
